Innovations and Patent Trends in the Development of USFDA Approved Protein Kinase Inhibitors in the Last Two Decades

Protein kinase inhibitors (PKIs) are important therapeutic agents. As of 31 May 2021, the United States Food and Drug Administration (USFDA) has approved 70 PKIs. Most of the PKIs are employed to treat cancer and inflammatory diseases. Imatinib was the first PKI approved by USFDA in 2001. This revie...

詳細記述

保存先:
書誌詳細
主要な著者: Mohd. Imran (著者), Syed Mohammed Basheeruddin Asdaq (著者), Shah Alam Khan (著者), Dhanalekshmi Unnikrishnan Meenakshi (著者), Abdulhakeem S. Alamri (著者), Walaa F. Alsanie (著者), Majid Alhomrani (著者), Yahya Mohzari (著者), Ahmed Alrashed (著者), Mohammed AlMotairi (著者), Eman H. Alkhaldi (著者), Abeer K. Alorabi (著者), Ahmed Subeh Alshrari (著者), Mohammad Tauseef (著者), Abida (著者), Saleh I. Alaqel (著者), Ozair Alam (著者), Md. Afroz Bakht (著者)
フォーマット: 図書
出版事項: MDPI AG, 2021-07-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

Connect to this object online.

3rd Floor Main Library

予約・返却請求 3rd Floor Main Library
請求記号: A1234.567
所蔵 1 利用可